610
SSGJ-610-BA-II-02
Phase 3 small_molecule active
Quick answer
610 for Asthma is a Phase 3 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active